Intravitreal bevacizumab in the management of neovascular age-related macular degeneration

Purpose: To study prospectively the safety and efficacy of intravitreal bevacizumab for eyes with neovascular age-related macular degeneration with baseline visual acuity better than 70 letters (Snellen equivalent better than 20/40). Methods: Patients with treatment-naive neovascular age-related mac...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	El-Mollayess, Georges M. (author)
مؤلفون آخرون:	Mahfoud, Ziyad (author), Schakal, Alexandre R. (author), Salti, Haytham I. (author), Jaafar, Dalida (author), Bashshur, Ziad F. (author)
التنسيق:	article
منشور في:	2013
الوصول للمادة أونلاين:	http://hdl.handle.net/10725/14095 https://doi.org/10.1097/IAE.0b013e3182877a0d http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://journals.lww.com/retinajournal/Fulltext/2013/10000/INTRAVITREAL_BEVACIZUMAB_IN_THE_MANAGEMENT_OF.10.aspx
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

الانترنت

http://hdl.handle.net/10725/14095
https://doi.org/10.1097/IAE.0b013e3182877a0d
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://journals.lww.com/retinajournal/Fulltext/2013/10000/INTRAVITREAL_BEVACIZUMAB_IN_THE_MANAGEMENT_OF.10.aspx

Intravitreal bevacizumab in the management of neovascular age-related macular degeneration

الانترنت

مواد مشابهة